Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mass neonatal screening using biological testing].

R Ardaillou1, J-Y Le Gall,

  • 1Académie nationale de médecine, 16, rue Bonaparte, 75006 Paris, France.

Gynecologie, Obstetrique & Fertilite
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Change in salt intake affects blood pressure of chimpanzees implications for human populations. Circulation 116: 1563-1568, 2007.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

COVID-19 epidemic phases: Criteria, challenges and issues for the future.

Bulletin de l'Academie nationale de medecine·2020
Same author

[Covid-19 epidemic phases: Criteria, challenges and issues for the future].

Bulletin de l'Academie nationale de medecine·2020
Same author

[The Albert Schweitzer legacy].

Medecine et sante tropicales·2013
Same author

[Gene therapy: its current place and its future].

La Revue de medecine interne·2002
Same author

Regulation of ANP clearance receptors by EGF in mesangial cells from NOD mice.

American journal of physiology. Renal physiology·2001
Same journal

[How I do… to see the sliding sign by transvaginal ultrasonography?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Cell-free fetal DNA screening tests for trisomy 21].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016
See all related articles

Neonatal screening programs identify severe, treatable diseases early. Expanding screening requires updated guidelines, ethical considerations, and long-term evaluation for improved infant health outcomes.

Area of Science:

  • Medical Genetics
  • Public Health
  • Pediatrics

Background:

  • Neonatal screening programs are crucial for early detection of severe diseases.
  • Established guidelines dictate disease inclusion based on severity, treatability, and public health impact.
  • France has a national screening program established in 1978, currently covering five diseases.

Framework:

  • Screening criteria include disease severity, early detectability, effective treatment availability, cost-effective testing, and significant health burden.
  • Positive results necessitate immediate treatment or prevention, with ongoing program evaluation.
  • Specific challenges exist for diseases like sickle cell disease and cystic fibrosis due to variable severity and lack of curative treatments.

Implementation:

  • Current French program includes phenylketonuria, hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis, and sickle cell disease (in at-risk newborns).

Related Experiment Videos

  • Toxoplasmosis screening is limited to specific high-risk scenarios.
  • Technological advancements like tandem mass spectrometry enable screening for numerous diseases simultaneously.

    • Implications:

    • Expanding neonatal screening raises ethical concerns regarding informing parents about incurable, late-onset, or asymptomatic conditions.
    • Future developments include updating screening guidelines, local pilot testing, establishing evaluation committees, defining carrier information protocols, and biobanking for research.